Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features

Lung Cancer

Volumn 65, Issue 3, 2009, Pages 385-387

  Duruisseaux, Michaël ^a   Cadranel, Jacques ^b   Biron, Elisabeth ^c   Pérol, Maurice ^a   Guérin, Jean Claude ^a   Arpin, Dominique ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c Centre Orthopédique Santy Hôpital Privé Jean Mermoz   (France)

Author keywords

Adenocarcinoma; Bronchioloalveolar carcinoma; Erlotinib; Lung cancer; Paclitaxel; Pemetrexed

Indexed keywords

CARBOPLATIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; GEFITINIB; HEMOGLOBIN; PACLITAXEL; PEMETREXED;

ADULT; AGED; ANEMIA; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BRONCHOSCOPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; KIDNEY FAILURE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BONE NEOPLASMS; COUGH; DISEASE PROGRESSION; DYSPNEA; FOLIC ACID; GLUTAMATES; GUANINE; HUMANS; KIDNEY FAILURE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NEUTROPENIA; REMISSION INDUCTION; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN B 12;

EID: 67651240361     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.02.018     Document Type: Article

References (17)

1. Travis W.D., Brambilla E., Muller-Hermelink H.K., et al. Pathology and genetics of tumors of the lung, pleura, thymus and heart. In World Health Organisation Classification of Tumours (2004), IARC Press, Lyon, France
2. Zell J.A., Ou S.-H.I., Ziogas A., et al. Epidemiology of bronchioloalveolar carcinoma: improvement of survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 23 (2005) 8396-8405
3. Read W.L., Page N.C., Tierney R.M., et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 45 (2004) 137-145
4. Garfield D.H., Cadranel J.L., Wislez M., et al. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol 4 (2006) 344-359
5. West H.L., Crowley J.J., Vance R.B., et al. Advanced bronchioloalveolar carcicoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group Study. Ann Oncol 16 (2005) 1076-1080
6. Scagliotti G.V., Smit E., Bosquee L., et al. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). Lung Cancer 50 (2005) 91-96
7. West H.L., Franklin W.A., McCoy J., et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group S0126. J Clin Oncol 24 (2006) 1807-1813
8. Cadranel J., Quoix E., Debove P., et al. Phase II study of gefitinib (IRESSA) administered as first line treatment in patients with non-resectable adenocarcinoma with bronchioloalveolar features-final results on efficacy and survival. J Clin Oncol 25 (2007) A7560
9. Miller V.A., Riely G.J., Zakowski M.F., et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar subtype, predict response to erlotinib. J Clin Oncol 25 (2008) 1472-1478
10. Chattopadhyay S., Moran R.G., and Goldmann I.D. Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther 6 (2007) 404-417
11. Hanna N., Shepherd F.A., Fossella F.V., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non small cell lung cancer previously treated with chemotherapy. J Clin Oncol 22 (2004) 1589-1597
12. Scagliotti G.V., Parikh P., von Pawel J., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 (2008) 3543-3551
13. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
14. Theti D.S., and Jackman A.L. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs. Clin Cancer Res 10 (2004) 1080-1089
15. Tracy S., Johnson E.B., and Jänne A.P. In-vitro effects of pemetrexed on bronchioloalveolar and adenocarcinoma of the lung. Proc Amer Assoc Cancer Res Meeting (2005) abstract #5864
16. Ho C., Ross H., and Davies A. Phase II trial of pemetrexed in patients with selected stage IIIB/IV bronchioloalveolar carcinoma. Clin Lung Cancer 8 (2006) 220-222
17. Cadranel J. Therapeutic strategy in advanced bronchioloalveolar carcinoma. October 5, 2006. Available at: http://clinicaltrials.gov/show/NCT00384826. Accessed September 26, 2008.